← Open Payments lookup

CAROL CROUCH-ROSS: Open Payments

NPI 1053466946 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,725 in 150 payments from 16 companies in 2025. Trend: 2023 $4,046 · 2024 $3,781 · 2025 $4,725

Food & beverage: $4,718Education: $8
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)32$1,088
Otsuka America Pharmaceutical, Inc.22$617
Axsome Therapeutics, Inc.14$617
Lundbeck LLC14$498
Teva Pharmaceuticals USA, Inc.12$436
E.R. Squibb & Sons, L.L.C.13$358
ABBVIE INC.8$291
Supernus Pharmaceuticals, Inc.16$269
Otsuka Pharmaceutical Development & Commercialization, Inc.2$219
Takeda Pharmaceuticals U.S.A., Inc.6$117

Products named: REXULTI, CAPLYTA, Auvelity, AUSTEDO XR, VRAYLAR, Qelbree, COBENFY, TRINTELLIX.

Industry payments across MI — which companies pay providers there.